MAGEA3 and breast carcinoma: Inokuma et al. previously showed low level MAGE-A3 T cell responses in healthy females which were increased in breast cancer patients [37], which corroborates our finding of spontaneous MAGE-A3 specific T cells in patients with benign diseases.